BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
4.300
-0.210 (-4.66%)
At close: Apr 28, 2026, 4:00 PM EDT
4.622
+0.322 (7.49%)
After-hours: Apr 28, 2026, 6:39 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $7.12 million as of April 28, 2026. Its market cap has decreased by -58.62% in one year.
Market Cap
7.12M
Enterprise Value
6.55M
1-Year Change
-58.62%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $7.12M, a decrease of -99.93%. That is a compound annual growth rate of -73.99%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 8.89M |
| NuCana | 8.57M |
| Creative Medical Technology Holdings | 8.50M |
| Silo Pharma | 8.13M |
| MetaVia | 8.06M |
| Processa Pharmaceuticals | 7.93M |
| TransCode Therapeutics | 7.81M |
| PharmaCyte Biotech | 7.75M |